↓ Skip to main content

Dove Medical Press

Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies

Overview of attention for article published in Neuropsychiatric Disease and Treatment, April 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
41 Mendeley
Title
Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies
Published in
Neuropsychiatric Disease and Treatment, April 2021
DOI 10.2147/ndt.s301225
Pubmed ID
Authors

Ágota Barabássy, Barbara Sebe, Károly Acsai, István Laszlovszky, Balázs Szatmári, Willie R Earley, György Németh

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 7%
Student > Master 3 7%
Other 3 7%
Researcher 3 7%
Student > Doctoral Student 2 5%
Other 7 17%
Unknown 20 49%
Readers by discipline Count As %
Psychology 4 10%
Medicine and Dentistry 4 10%
Unspecified 3 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Neuroscience 2 5%
Other 5 12%
Unknown 20 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2021.
All research outputs
#16,718,581
of 25,388,177 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,716
of 3,125 outputs
Outputs of similar age
#256,497
of 433,361 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#29
of 53 outputs
Altmetric has tracked 25,388,177 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,125 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,361 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.